In October 2021, Finnish startup Surgify’s bone cutting technology was taken into use on patients at Helsinki University Hospital.
“The two surgical patients recovered well from their surgeries and returned home quickly. Neither faced soft tissue damage during the operation,” says Head of HUS Neurosurgery and Professor Mika Niemelä. “Surgify’s device appears to push the soft tissue out of the way. This is a major advantage, as a typical surgical drill that spins tens of thousands of times in a minute can be very dangerous if it touches soft tissue.”
The company’s technology speeds up the surgeon’s work, increases the safety and accuracy of surgery, and protects patients’ lives, states the company. When the soft tissue is not damaged, the patient needs less treatment, recovers faster, and postoperative complications are less likely. Clinical procedures with Surgify’s new technology will continue at HUS, reports the company.
“We see our solution as part of a bigger change that is happening in surgery, and that enables wider use of automation in many types of procedures. We envision enabling surgeons to perform their surgical skills beyond the limitations of current surgical instrumentation, allowing best-in-class surgical procedures for every patient and cost-efficient innovation for the health system,” says Surgify’s CEO, Visa Sippola.
Targeting the international market
Next, Surgify targets the international market with its product. Their internationalization strategy is sharpened by their newly appointed Chair of Board, Lex R. Giltaij. He has been serving for more than 30 years in senior executive positions creating and building international businesses for many orthopedic and spinal companies, amongst them Stryker, St. Francis Medical Technology (now Medtronic), and Pioneer Surgical (now RTI Surgical), describes Surgify in its press release.
“We’re starting in the Nordic countries and will soon take our groundbreaking technology to the international markets in the EU and USA. We are also looking forward to continuing our effective collaboration work with HUS,” says Giltaij.
Photo of the Surgify team